BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12637790)

  • 1. Endocrine and non-endocrine actions of ghrelin.
    Broglio F; Gottero C; Arvat E; Ghigo E
    Horm Res; 2003; 59(3):109-17. PubMed ID: 12637790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin: endocrine, metabolic and cardiovascular actions.
    Broglio F; Prodam F; Me E; Riganti F; Lucatello B; Granata R; Benso A; Muccioli G; Ghigo E
    J Endocrinol Invest; 2005; 28(5 Suppl):23-5. PubMed ID: 16114271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
    van der Lely AJ; Tschöp M; Heiman ML; Ghigo E
    Endocr Rev; 2004 Jun; 25(3):426-57. PubMed ID: 15180951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin: a new hormone with endocrine and non-endocrine activities.
    Baldelli R; Bellone S; Broglio F; Ghigo E; Bona G
    Pediatr Endocrinol Rev; 2004 Sep; 2(1):8-14. PubMed ID: 16429099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
    Ghigo E; Broglio F; Arvat E; Maccario M; Papotti M; Muccioli G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin: much more than a natural growth hormone secretagogue.
    Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Granata R; Papotti M; Muccioli G; Deghenghi R; Ghigo E
    Isr Med Assoc J; 2002 Aug; 4(8):607-13. PubMed ID: 12183865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral activities of ghrelin, a ligand of the growth hormone secretagogue receptor.
    Bona G; Bellone S
    Panminerva Med; 2003 Sep; 45(3):197-201. PubMed ID: 14618118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and synthetic growth hormone secretagogues: do they have therapeutic potential?
    Broglio F; Arvat E; Gottero C; Benso A; Prodam F; Destefanis S; Aimaretti G; Papotti M; Muccioli G; Deghenghi R; Ghigo E
    Treat Endocrinol; 2003; 2(3):153-63. PubMed ID: 15966564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome.
    Giordano R; Picu A; Broglio F; Bonelli L; Baldi M; Berardelli R; Ghigo E; Arvat E
    Pituitary; 2004; 7(4):243-8. PubMed ID: 16132204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of ghrelin secretion and action.
    Camiña JP; Carreira MC; Micic D; Pombo M; Kelestimur F; Dieguez C; Casanueva FF
    Endocrine; 2003 Oct; 22(1):5-12. PubMed ID: 14610293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.
    Rubinfeld H; Hadani M; Taylor JE; Dong JZ; Comstock J; Shen Y; DeOliveira D; Datta R; Culler MD; Shimon I
    Eur J Endocrinol; 2004 Dec; 151(6):787-95. PubMed ID: 15588247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity.
    Muccioli G; Tschöp M; Papotti M; Deghenghi R; Heiman M; Ghigo E
    Eur J Pharmacol; 2002 Apr; 440(2-3):235-54. PubMed ID: 12007539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and synthetic GH secretagogues.
    Arvat E; Broglio F; Aimaretti G; Benso A; Giordano R; Deghenghi R; Ghigo E
    Best Pract Res Clin Endocrinol Metab; 2002 Sep; 16(3):505-17. PubMed ID: 12464231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The many faces of ghrelin: new perspectives for nutrition research?
    Otto B; Spranger J; Benoit SC; Clegg DJ; Tschöp MH
    Br J Nutr; 2005 Jun; 93(6):765-71. PubMed ID: 16022744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.
    Volante M; Allìa E; Gugliotta P; Funaro A; Broglio F; Deghenghi R; Muccioli G; Ghigo E; Papotti M
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1300-8. PubMed ID: 11889202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin--not just another stomach hormone.
    Wang G; Lee HM; Englander E; Greeley GH
    Regul Pept; 2002 May; 105(2):75-81. PubMed ID: 11891007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
    Korbonits M; Bustin SA; Kojima M; Jordan S; Adams EF; Lowe DG; Kangawa K; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin: endocrine and non-endocrine actions.
    Broglio F; Arvat E; Benso A; Papotti M; Muccioli G; Deghenghi R; Ghigo E
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1219-27. PubMed ID: 12510973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.